Prevalence of Acute Kidney Injury in Covid-19 Patients- Retrospective Single-Center Study

Ahmed Muhammad Bashir1, Mahad Sadik Mukhtar2, Yahye Garad Mohamed3

  • 1Department of Internal Medicine, Mogadishu Somali Turkey, Recep Tayyip Erdogan, Training and Research Hospital, Mogadishu, Somalia.

Insights

Acute kidney injury (AKI) affects 12.7% of COVID-19 patients, correlating with inflammatory markers like CRP and ferritin. Early vigilance for kidney injury is crucial, especially in severe COVID-19 cases.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to widespread global health challenges.
  • Beyond respiratory distress, COVID-19 is associated with multi-organ involvement, necessitating a comprehensive understanding of its systemic effects.
  • Acute kidney injury (AKI) is an emerging concern in COVID-19 patients, impacting prognosis and requiring further investigation.

Purpose of the Study:

  • To determine the prevalence of AKI in COVID-19 patients.
  • To investigate the relationship between inflammatory markers (CRP, ferritin) and AKI in COVID-19.
  • To assess the association between lung involvement severity and AKI in COVID-19 patients.

Main Methods:

  • Retrospective analysis of 102 COVID-19 patients admitted during the second wave in 2021.
  • Collection of demographic data, comorbidities, laboratory values (hemoglobin, platelets, WBC, glucose, urea, creatinine, electrolytes, CRP, ferritin), RT-PCR results, and CT scan findings.
  • Statistical analysis to determine the prevalence of AKI and its association with inflammatory markers and lung injury severity.

Main Results:

  • The prevalence of AKI among COVID-19 patients was 12.7%.
  • Significant associations were found between AKI and elevated CRP (P<0.003) and ferritin (P<0.004).
  • Severe lung involvement on CT scans showed significant associations with higher CRP (P<0.007) and ferritin (P<0.005) levels.

Conclusions:

  • AKI is a common complication in COVID-19 patients, contributing to increased morbidity and mortality.
  • Inflammatory markers such as CRP and ferritin are significantly associated with both AKI and lung injury severity in COVID-19.
  • Clinicians, particularly in resource-limited settings, must maintain heightened awareness for kidney injury in patients with severe COVID-19.
Abstract

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
106
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
69
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
127
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
130
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
56
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
83